Avalyn Pharma Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF (NCT07194382) | Avalyn Pharma Inc. | 2026-03-10 |
| An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) (NCT06951217) | Avalyn Pharma Inc. | 2025-04-17 |
| A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis (NCT06329401) | Avalyn Pharma Inc. | 2024-04-03 |
Track Avalyn Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.